In recent years, uPA and uPAR have also been regarded as diagnostic and prognostic markers in cancer, and high levels of both uPA and uPAR in tissue and serum have been demonstrated to correlate with a poor patient outcome in different types of primary as well as metastatic malignancies [8,11,12,13,14,15,16]. Here, PLAU is linked to cancer.